Published in AIDS Weekly, October 2nd, 2006
Study 1: Visceral leishmaniasis/HIV coinfection is increasing in India.
"India contributes heavily to the global burden of visceral leishmaniasis (VL, kala-azar) and human immunodeficiency virus (HIV)/AIDS. The prevalence of HIV seropositivity in VL patients at a tertiary care centre in northern India, as observed during a prospective study over a period of 2 years, is presented," investigators in India report.
According to P. Mathur and colleagues at the All India Institute of Medical Sciences in New Delhi, "Of the 104 cases of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-10-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.